These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35193616)

  • 1. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
    Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H
    Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVAX, vaccine donations and the politics of global vaccine inequity.
    de Bengy Puyvallée A; Storeng KT
    Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
    Pilkington V; Keestra SM; Hill A
    Front Public Health; 2022; 10():821117. PubMed ID: 35321196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Race for Global Equitable Access to COVID-19 Vaccines.
    Md Khairi LNH; Fahrni ML; Lazzarino AI
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
    Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities to accelerate immunization progress in middle-income countries.
    Zhu J; Cole CB; Fihman J; Adjagba A; Dasic M; Cernuschi T
    Vaccine; 2024 Apr; 42 Suppl 1():S98-S106. PubMed ID: 37460357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVAX and equitable access to COVID-19 vaccines.
    Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
    Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes and costs of global COVID-19 vaccine inequity.
    Ferranna M
    Semin Immunopathol; 2024 Jan; 45(4-6):469-480. PubMed ID: 37870569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution.
    Agampodi S; Mogeni OD; Chandler R; Pansuriya M; Kim JH; Excler JL
    Expert Rev Vaccines; 2024; 23(1):761-772. PubMed ID: 39167221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dilemma, causes and countermeasures of global health governance: taking COVID-19 Vaccines Global Access Facility as an example].
    Bai AY; Zhang B; Jiang Y; Qiao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):483-487. PubMed ID: 35443301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa.
    Hassan MA; Aliyu S
    Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charity or empowerment? The role of COVAX for low and middle-income countries.
    Holzer F; Roa TM; Germani F; Biller-Andorno N; Luna F
    Dev World Bioeth; 2023 Mar; 23(1):59-66. PubMed ID: 35307947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine inequity in African low-income countries.
    Kunyenje CA; Chirwa GC; Mboma SM; Ng'ambi W; Mnjowe E; Nkhoma D; Ngwira LG; Chawani MS; Chilima B; Mitambo C; Crampin A; Mfutso-Bengo J
    Front Public Health; 2023; 11():1087662. PubMed ID: 36950103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.
    Rogers AB; Barrie MB; Fallah MP; Kelly JD
    Am J Trop Med Hyg; 2021 Jun; 105(2):278-280. PubMed ID: 34181573
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.